杜比卢马布治疗慢性手湿疹:系统性审查和元分析
Hannah R Riva1, Teresa Yoon1, Aleksi J Hendricks2
1From the Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA.
Dermatitis : contact, atopic, occupational, drug
|November 6, 2024
概括
杜皮卢马布有效治疗慢性手湿疹 (CHE),有80.3%的患者在16周内出现改善. 这种IL-4/13抑制剂对各种CHE亚型具有治疗效益,尽管对特定形式需要进一步研究.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性手湿疹 (CHE) 是一种流行且具有挑战性的皮肤病.
- 杜皮卢马布是一种IL-4/13抑制剂,已在亚托皮性皮肤炎 (AD) 中表现出有效性,并正在对CHE进行研究.
研究的目的:
- 评估dupilumab在治疗慢性手湿疹 (CHE) 的治疗疗效.
- 评估dupilumab在各种CHE亚型和患者群体中的有效性.
主要方法:
- 在PubMed数据库上进行了系统的文献搜索,使用与dupilumab和慢性手湿疹相关的术语.
- 分析了22篇出版物,包括临床试验,观察性研究,病例系列和涉及374名患者的病例报告.
- 关于治疗反应,不同CHE亚型的疗效,生活质量和不良事件的数据被提取和评估.
主要成果:
- 在4至16周内,在80.3%的患者中,dupilumab治疗导致CHE的部分或完全消失.
- 在手湿疹严重程度和生活质量得分上观察到显著的改善.
- 在CHE亚型中,疗效有所不同,与超皮性CHE相比,在脱水性,膀性,亚托皮性和接触性CHE中,应答率更高.
结论:
- 杜皮卢马布在慢性手湿疹 (CHE) 中表现出显著的治疗疗效.
- 患有亚托皮性皮炎 (AD) 病史的患者在使用dupilumab时表现出增强的改善.
- 进一步的随机对照研究是有必要的,以探索dupilumab在特定CHE亚型中的疗效.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97
01:23Hand hygiene
3.1K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
3.1K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
149
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
149
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
240
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240